Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivax Bio is a biotechnology company specializing in the development of advanced 3D bioprinting technologies for tissue engineering and regenerative medicine. The company's platform utilizes proprietary bio-inks and high-precision bioprinting systems to create functional human tissues, such as skin, liver, and cardiac models, for use in drug discovery and toxicity testing. By providing human-relevant tissue models, Vivax Bio aims to reduce the reliance on animal testing and accelerate the drug development process with more accurate data. The company is also exploring long-term applications in the creation of transplantable organs and personalized medicine solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivax.